A detailed history of Black Rock Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Black Rock Inc. holds 43,704,401 shares of TEVA stock, worth $721 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,704,401
Previous 41,664,861 4.9%
Holding current value
$721 Million
Previous $435 Million 41.77%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $21.8 Million - $29.4 Million
2,039,540 Added 4.9%
43,704,401 $617 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $7.16 Million - $9.37 Million
881,566 Added 2.16%
41,664,861 $435 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $3.69 Million - $5.28 Million
493,488 Added 1.22%
40,783,295 $416 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $888,667 - $1.17 Million
123,426 Added 0.31%
40,289,807 $303 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $1.59 Million - $2.16 Million
-190,344 Reduced 0.47%
40,166,381 $355 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $10.4 Million - $12.4 Million
-1,310,529 Reduced 3.15%
40,356,725 $368 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $9.67 Million - $16.9 Million
-1,410,349 Reduced 3.27%
41,667,254 $336 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $10.5 Million - $14.9 Million
1,428,887 Added 3.43%
43,077,603 $324 Million
Q1 2022

May 12, 2022

BUY
$7.33 - $9.39 $11 Million - $14 Million
1,494,814 Added 3.72%
41,648,716 $391 Million
Q4 2021

Feb 10, 2022

SELL
$7.9 - $10.19 $3.06 Million - $3.95 Million
-387,943 Reduced 0.96%
40,153,902 $322 Million
Q3 2021

Nov 09, 2021

BUY
$8.38 - $10.18 $6.59 Million - $8 Million
785,802 Added 1.98%
40,541,845 $395 Million
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $394 Million - $460 Million
39,756,043 New
39,756,043 $394 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.